课题基金 / 基金详情

Elucidation of mechanisms of pancreatic oncogenesis and establishment of novel therapy by modulating Notch signaling

Elucidation of mechanisms of pancreatic oncogenesis and establishment of novel therapy by modulating Notch signaling
阐明胰腺肿瘤发生机制并通过调节 Notch 信号建立新疗法
批准号:
15590615
负责人:
KIMURA Kenji
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

KIMURA Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
[Background]Although it is reported that Notch signaling is activated in various cancer cells, the role of Notch signaling at early stage of oncogenesis in pancreas.[Aim]To establish novel mouse pancreatic cancer model using green mouse.To investigate the role of Notch signaling on pancreatic oncogenesis.[Results]1)Notch1 was expressed from PanIN-1A to invasive carcinoma.2)Tubular complex was detected in pancreas two weeks after DMBA injection. PanIN-2 lesion was observed in pancreas one month after DMBA injection. Invasive carcinoma occurred more than two months after DMBA injection. Tumor cells were CK-positive, vimentin-negative.3)Smad4 was downregulated in invasive carcinoma. CyclinD1 and p53 were upregulated in invasive carcinoma.4)Notch1 mRNA was upregulated in PanIN lesion and Invasive carcinoma. PDx1 mRNA was upregulated in PanIN lesion and Invasive carcinoma.[Conculusions]We established novel mouse pancreatic cancer model. Notch signaling was upregulated at early stage of oncogenesis. Notch inhibits differentiation in pancreatic cancer cells.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
The Role of Notch Signaling Pathway in Pancreatic Cancer Cells
Notch信号通路在胰腺癌细胞中的作用
DOI: --
发表时间: 2004
期刊: Pancreatology 4・3
影响因子: --
作者: [Kimura K, Satoh K, Hamada S, Shimosegawa T]
通讯作者: Shimosegawa T
4-hydroxy-2,3-nonenal activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells.
4-羟基-2,3-nonenal 激活大鼠胰腺星状细胞中的激活蛋白-1 和丝裂原激活蛋白激酶。
DOI: --
发表时间: 2004
期刊: World J of Gastroenterology 10・16
影响因子: --
作者: [Kikuta K, Masamune A, Satoh M, Suzuki N, Shimosegawa T]
通讯作者: Shimosegawa T
MSX2 Enhances Malignant Phenotype of Human Pancreatic Cancer Cell Line BxPC-3
MSX2 增强人胰腺癌细胞系 BxPC-3 的恶性表型
DOI: --
发表时间: 2004
期刊: Pancreatology 4・3
影响因子: --
作者: [Satoh K, Hamada S, Kimura K, Shimosegawa T]
通讯作者: Shimosegawa T
Hereditary pancreatitis as the premalignant disease : a Japanese case of pancreatic cancer involving the SPINK1 gene mutation N34S.
遗传性胰腺炎作为癌前疾病:日本一例涉及 SPINK1 基因突变 N34S 的胰腺癌。
DOI: --
发表时间: 2004
期刊: Pancreas 28・3
影响因子: --
作者: [Masamune A, Mizutamari H, Kume K, Satoh K, Shimosegawa T]
通讯作者: Shimosegawa T
13
    manufacturing of nano pores for handling of a DNA molecule
    • 批准号:
      24651114
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2012
    • 负责人:
      KIMURA Kenji
    • 依托单位:
    Improvement of sensitivity in high-resolution RBS
    • 批准号:
      21360022
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2009
    • 负责人:
      KIMURA Kenji
    • 依托单位:
    Basic research for development of electronics devices with strain-Si
    • 批准号:
      17360139
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.33万
    • 财政年份:
      2005
    • 负责人:
      KIMURA Kenji
    • 依托单位:
    A History of Performances of Greek and Roman Dramas
    • 批准号:
      14510646
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      2002
    • 负责人:
      KIMURA Kenji
    • 依托单位:
    国内基金
    海外基金
    基于 ANKRD22 介导的脂代谢重编程激活Notch4/HES1 通路促进巨噬细胞获得免疫抑制表型机制研究
    • 批准号:
      ZCLMS26H1601
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      肖于飞
    • 依托单位:
    电针调控 Notch 信号通路促进脑缺血再灌注损伤神经血管单元调节和保护作用
    • 批准号:
      2026JJ82306
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      袁高明
    • 依托单位:
    超级增强子NFIX-SE募集MEF2C激活NFIX/NOTCH通路增强肿瘤细胞干性导致小细胞肺癌化疗耐药的机制研究
    • 批准号:
      2026JJ81772
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      童琴
    • 依托单位:
    MPE细胞团中α-SMA+肿瘤细胞激活Notch 通路促恶性进展的作用机制研究
    • 批准号:
      JCZRQNB202600536
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: